630122-84-8

Basic information

• Product Name: N-methyl-C-[4-(6-{4-[3-(4-morpholin-4-yl-3-trifluoromethyl-phenyl)ureido]phenoxy}pyrimidin-4-ylamino)phenyl]-methanesulfonamide
• Synonyms: N-methyl-C-[4-(6-{4-[3-(4-morpholin-4-yl-3-trifluoromethyl-phenyl)ureido]phenoxy}pyrimidin-4-ylamino)phenyl]-methanesulfonamide
• CAS NO: 630122-84-8
• Molecular Weight: 657.673
• Mol File: 630122-84-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-methyl-C-[4-(6-{4-[3-(4-morpholin-4-yl-3-trifluoromethyl-phenyl)ureido]phenoxy}pyrimidin-4-ylamino)phenyl]-methanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-methyl-C-[4-(6-{4-[3-(4-morpholin-4-yl-3-trifluoromethyl-phenyl)ureido]phenoxy}pyrimidin-4-ylamino)phenyl]-methanesulfonamide(630122-84-8)
• EPA Substance Registry System: N-methyl-C-[4-(6-{4-[3-(4-morpholin-4-yl-3-trifluoromethyl-phenyl)ureido]phenoxy}pyrimidin-4-ylamino)phenyl]-methanesulfonamide(630122-84-8)

Safety Data

• Hazardous Substances Data: 630122-84-8(Hazardous Substances Data)

Upstream product

• 105316-06-1 4-morpholin-4-yl-3-(trifluoro-methyl)aniline 

Relevant articles and documents

DIARYL UREA DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES

The invention relates to the use of diaryl urea derivatives in the treatment of protein kinase dependent diseases or for the manufacture of pharmaceutical compositions for use in the treatment of said diseases, methods of use of diaryl urea derivatives in the treatment of said diseases, pharmaceutical preparations comprising diaryl urea derivatives for the treatment of said diseases, diaryl urea derivatives for use in the treatment of said diseases, novel diaryl urea derivatives, pharmaceutical preparations comprising these novel diaryl urea derivatives, processes for the manufacture of the novel diaryl urea derivatives, the use or methods of use of the novel diaryl urea derivatives as mentioned above, and/or these novel diaryl urea derivatives for use in the treatment of the animal or human body.